Funding

Khartis Therapeutics

United States · Biotech · Healthtech

Develops oral small molecule therapies for immunological and chronic diseases

Visit khartis.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series B$50MAlexandria Venture Investments — Role not disclosedForesite Capital — Role not disclosedForge Life Science Partners — Role not disclosedLilly Asia Ventures — Role not disclosedLongwood Fund — Role not disclosedNextech Invest — Role not disclosed

Investors

Alexandria Venture InvestmentsSeries BForesite CapitalSeries BForge Life Science PartnersSeries BLilly Asia VenturesSeries BLongwood FundSeries BNextech InvestSeries B

Coverage

Aug 13, 2026Khartis Therapeutics · Series B

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
Sourceskhartis.com ↗